Clinical trial
Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary…
NCT00046319 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00046319 |
|---|---|
| Title | Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension |
| Official title | A Phase II, Randomized, Double-Blind, Dose-Controlled, Dose-Ranging, Multicenter Study of BSF 208075 Evaluating Exercise Capacity in Patients With Moderate to Severe Pulmonary Arterial Hypertension |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | BSF 208075 |
| Enrollment | 60 |
| Start date | Sep 1, 2002 |
| Completion | Jun 1, 2003 |
| First posted | Sep 30, 2002 |
| Last update posted | Apr 16, 2009 |
| Countries | Australia, Belgium, France, Germany, Italy, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: